Evidence map›Paper›PMID 25703191›Full record

ArticleInternational journal of geriatric psychiatry2015

Glycemic control, inflammation, and cognitive function in older patients with type 2 diabetes.

Jimmy Akrivos, Ramit Ravona-Springer, James Schmeidler, Derek LeRoith, Anthony Heymann, Rachel Preiss, Hadas Hoffman, Keren Koifman, Jeremy M Silverman, Michal Schnaider Beeri

Abstract read
In one paragraph

Article in International journal of geriatric psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jimmy AkrivosDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ramit Ravona-SpringerThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.
James SchmeidlerDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Derek LeRoithDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Anthony HeymannMaccabi Healthcare Services, Tel Aviv, Israel.
Rachel PreissMaccabi Healthcare Services, Tel Aviv, Israel.
Hadas HoffmanMaccabi Healthcare Services, Tel Aviv, Israel.
Keren KoifmanThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.
Jeremy M SilvermanDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Michal Schnaider BeeriDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Funding

Inflammation, long-term diabetes characteristics, and cognitive declineR01AG034087 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNAIDER BEERI, MICHAL · 2009 to 2014
$3.7M
NIA NIH HHS R01 AG034087
6 · The paper itself

Abstract

objectiveGlycated hemoglobin (HbA1c) and C-reactive protein (CRP) have been associated with cognitive impairment independently. However, it is unclear if their combination exacerbates poor cognitive function. We assessed whether long-term glycemic level and glycemic variability modulate the association of systemic inflammation with cognitive function, in a sample of cognitively normal older people with type 2 diabetes.

methodsA retrospective cohort study of 777 randomly selected participants from ~11,000 patients in the Maccabi Healthcare Services Diabetes Registry, as part of the Israel Diabetes and Cognitive Decline study. Subjects averaged 18 (±9.4) HbA1c measures in the Maccabi Healthcare Services Registry, which were used to calculate long-term glycemic level (HbA1c-mean) and glycemic variability (HbA1c-standard deviation (SD)). Linear regression models assessed the interactions of CRP, a marker of systemic inflammation, with HbA1c-mean and HbA1c-SD on subjects' performance in tests of Memory, Executive Functions, Attention, and Semantic Categorization.

resultsQuadratic interactions of CRP with HbA1c-SD approached significance for executive functions and overall cognition. However, after Bonferroni adjustment, none of the interactions of CRP with HbA1c were statistically significant. In partial correlations according to HbA1c-SD tertiles, CRP was weakly correlated in the middle tertile with decreased performance in the domains of semantic categorization (r = -0.166, p = 0.011), executive functions (r = -0.136, p = 0.038), and overall cognition (r = -0.157, p = 0.016).

conclusionsGlycated hemoglobin does not substantially modulate the association of CRP with cognition in a sample of cognitively normal, community dwelling older people with relatively well-managed type 2 diabetes.

Indexed as

C-Reactive ProteinGlycated HemoglobinAdultAgedAttentionBiomarkersBlood GlucoseCognitionDiabetes Mellitus, Type 2Executive FunctionFemaleHumansInflammationIsraelMaleMemoryBiomarkersBlood GlucoseC-Reactive ProteinGlycated Hemoglobincognitive functionC-reactive proteinHbA1colder peopletype 2 diabetes

Identifiers

PMID25703191
PMCPMC5753409

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.